Latest Strategy News

Zenith Minerals has validated a large-scale gold system at its Red Mountain project and initiated its largest ever drilling campaign at Consolidated Dulcie, backed by a strong A$11.15 million capital raise.

James Hardie confirms key board changes and underscores its commitment to shareholder value amid strong integration progress with AZEK.

Althea Group Holdings reported a resilient September quarter with $5.4 million in receipts despite a major strike in British Columbia, bolstered by a $2.53 million capital raise and expansion in the US THC beverage market.

Tanami Gold NL reports significant gold intercepts from ongoing drilling at the Jims Gold Mine, while Mount Gibson Iron moves to acquire Northern Star’s stake in the Central Tanami Project joint venture.

Southern Palladium has cleared major regulatory hurdles and confirmed robust economics for its Bengwenyama platinum group metals project, supported by a $20 million capital raise to fund next-stage development.

Firebrick Pharma is set to expand its Nasodine product line with the launch of a new throat spray, targeting export markets starting November 2025, beginning with Singapore.

Anax Metals has made significant progress on its Whim Creek Copper-Zinc project, securing a waste rock processing agreement and continuing efforts to finalize project financing.

Felix Gold has revealed two new massive surface stibnite discoveries at its Treasure Creek project in Alaska, significantly expanding the known high-grade antimony mineralisation. These findings, alongside robust drilling results, reinforce the project's potential to address critical US supply shortages amid global market disruptions.

Magnetite Mines has made significant strides in developing its Razorback Iron Ore Project, securing $3.86 million in new funding and uncovering promising rare earth mineralisation at Ironback Hill. The company continues to navigate strategic partnerships and regulatory approvals to advance its long-life magnetite project.

CONNEQT Health reports robust 50% quarter-on-quarter growth in Pulse device sales and launches a new pricing strategy to boost recurring revenue. The company also secures a significant US clinical trial contract and advances cost-cutting efforts.

Cleo Diagnostics has successfully completed Stage 1 of the Medical Device Single Audit Program, marking a significant step toward FDA submission and global commercialisation of its ovarian cancer test.

Horizon Oil’s recent acquisition of Thai gas assets and a decade-long permit extension at Maari have propelled production and reserves, underpinning a strong financial quarter and sustained shareholder returns.